Immediate and short-term prevalence of depression in covid-19 patients and its correlation with continued symptoms experience
Authors:
Open Access
- 1 May 2022
- journal article
- research article
- Published by Medknow in Indian Journal of Psychiatry
- Vol. 64 (3) , 301-306
Abstract
Background: The COVID-19 infection can result in prolonged illness in those infected irrespective of disease severity. Infectious diseases are associated with a higher risk of mood disorders. A better understanding of convalescence, symptom duration, as well as the prevalence of depression among recovering patients, could help plan better care for the survivors of COVID-19. Aim: The study aimed to estimate the immediate and short-term prevalence of major depressive disorder and its correlation with continued symptom experience. Methods: In this non-interventional, observational, and cross-sectional telephone survey study, 273 participants were included from January 2021 to April 2021 and 261 completed follow-up by July 2021. The symptoms at the time of RT-PCR testing and during the two phone calls were captured and the Patient Health Questionnaire 9 item (PHQ-9) version was administered. Results: During the immediate and short-term period following COVID-19, 144/261 (55.1%) and 71/261 (27.2%) patients had not returned to usual health, respectively, and 33/261 (12.8%) and 13/261 (5%) of the patients developed depression, respectively. The binary logistic regression analysis revealed that the independent predictors of depression in short-term period following COVID-19 were comorbid diabetes mellitus (OR = 32.99, 95% CI- 2.19-496, P = 0.011), number of symptoms at the time of RT-PCR testing (OR = 1.89, 95% CI 1.23-1.92, P = 0.018), and number of symptoms at short-term period following COVID-19 (OR = 2.85, 95% CI 1.47-5.51, P = 0.002). Conclusions: Individuals with a greater number of symptoms at the time of RT-PCR testing, with post-COVID symptoms persisting 3 months later, and those who have comorbid diabetes mellitus, are at greater odds to have comorbid depression.Keywords
This publication has 25 references indexed in Scilit:
- The psychological and mental impact of coronavirus disease 2019 (COVID-19) on medical staff and general public – A systematic review and meta-analysisPsychiatry Research, 2020
- Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: A cross‐sectional evaluationJournal of Medical Virology, 2020
- What can psychiatrists learn from SARS and MERS outbreaks?The Lancet Psychiatry, 2020
- Clinical features and outcomes of discharged coronavirus disease 2019 patients: a prospective cohort studyQJM: An International Journal of Medicine, 2020
- Comorbid depression and risk of cardiac events and cardiac mortality in people with diabetes: A systematic review and meta-analysisDiabetes Research and Clinical Practice, 2019
- Validation of the telephone-administered PHQ-9 against the in-person administered SCID-I major depression moduleJournal of Affective Disorders, 2013
- Assessing depression in primary care with the PHQ-9: Can it be carried out over the telephone?Journal of General Internal Medicine, 2005
- The PHQ-9Journal of General Internal Medicine, 2001
- Validation and Utility of a Self-report Version of PRIME-MDThe PHQ Primary Care StudyJAMA, 1999